XTL Biopharmaceuticals Ltd.

Biotech company $XTLB shares have surged more than 200% this week after it said it has entered into a binding term sheet to acquire The Social Proxy Ltd., a web data AI firm. The acquisition is part of their strategy to enhance its asset portfolio with a focus on AI and business intelligence applications.

Share This Article

 

About the Author

XTL Biopharmaceuticals Ltd.

Joey Ramson